15q13.3 microduplication syndrome

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

Random or autosomal dominanat disorder caused by extra piece of genetic information long arm of chromosome 15 causing mental and physical development deficits.

Common symptoms

Mental deficits (Intellectual disabilitycommunication difficultiesbehavioral and psychiatric problemsautistic featuresemotional instabilityattention-deficit hyperactivity disorder (ADHD)schizophreniadifficulty sleeping) and physical deficits (feeding problemslow muscular toneseizurescleft palate (CHRNA7 gene duplication))

When to suspect

  • Recommendation 1

    Physical exam findings (feeding problems, developmental delay, intellectual disability, or behavioral problems) plus genetic testing using chromosomal microarray (CMA) to confirm diagnosis

How to test

  • Recommendation 1

    Physical exam findings (feeding problems, developmental delay, intellectual disability, or behavioral problems) plus genetic testing using chromosomal microarray (CMA) to confirm diagnosis

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Epilepsy is treated with anti-seizure medication (ASM).

Primary care

  • Recommendation 1

    Learning and communication deficits can be managed through various therapies

Further support

  • Recommendation 1

    Dup15q Alliance recommends multiple clinics which can be found here. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 15q13.3 microduplication syndrome?

Follow to receive regular updates to the latest research development on this disease via email newsletter.